Precision Cancer Treatment: How Brachytherapy Delivers Targeted Radiotherapy
July 2, 2025 – As cancer treatment advances, the focus has increasingly shifted toward therapies that precisely target tumors while preserving surrounding healthy tissue. One such breakthrough is brachytherapy, a highly focused form of internal radiotherapy, recently spotlighted by the International Atomic Energy Agency (IAEA) for its precision and effectiveness.
Unlike conventional radiation therapy, which directs external beams through the body, brachytherapy involves placing radioactive sources directly inside or near the tumor. These tiny implants—often as small as a grain of rice—emit radiation over a short distance, ensuring that cancer cells receive a potent dose while nearby organs and tissues are largely spared.
This localized approach allows doctors to intensify treatment where it’s needed most, reducing side effects and improving patient outcomes. The technique can be either temporary or permanent. In temporary procedures, the source is removed after a set period. In permanent brachytherapy, the implanted seeds lose their radioactivity naturally over time, requiring no further intervention.
Brachytherapy is used to treat a range of cancers, including prostate, cervical, breast, skin, and head and neck cancers. It is especially effective for tumors that are localized and slow-growing, where maintaining the health of surrounding tissue is crucial.
The IAEA supports global access to brachytherapy by providing training, equipment guidelines, and safety protocols. Their efforts ensure that even low-resource countries can offer this advanced treatment with high safety standards.
In the global fight against cancer, brachytherapy represents a modern, targeted solution—delivering strong therapeutic effects directly to cancerous tissue while minimizing harm. Its precision, effectiveness, and adaptability make it a critical tool in the arsenal of modern oncology.
